{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T21:38:56Z","timestamp":1783719536535,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700149"],"award-info":[{"award-number":["81700149"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103098"],"award-info":[{"award-number":["82103098"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Recently, some methyltransferase-like (METTL) proteins have been found to play crucial roles in the development of acute myeloid leukemia (AML) through mediating RNA modifications, such as METTL3\/14\/16 mediated N<jats:sup>6<\/jats:sup>-methyladenosine (m<jats:sup>6<\/jats:sup>A) and METTL1 mediated N<jats:sup>7<\/jats:sup>-methylguanosine (m<jats:sup>7<\/jats:sup>G). However, the roles of other METTL proteins in AML progression remain unknown. Here, we examined the expression levels of all METTL members in AML samples and showed that METTL13 was increased in AML and positively correlated with poor prognosis. Moreover, METTL13 deficiency impaired AML cell proliferation capability in vitro, improved the survival of AML cell line xenograft immune-deficient mice, and reduced tumor infiltration in vivo. Mechanistically, MYC was downregulated after METTL13 knockdown and forced expression of MYC rescued the cell proliferation defect in METTL13-deficient AML cells. Our findings uncover the critical role of METTL13 in the survival of AML cells and identify MYC as a potential downstream target of METTL13. This work highlights METTL13 as a promising candidate target for AML therapy.<\/jats:p>","DOI":"10.1038\/s41420-025-02512-x","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T13:51:44Z","timestamp":1747489904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["METTL13 is essential for the survival of acute myeloid leukemia cells by regulating MYC"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9338-6675","authenticated-orcid":false,"given":"Kui","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuoting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhishuai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoqiang","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaisong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6896-8657","authenticated-orcid":false,"given":"Yanqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1612-6711","authenticated-orcid":false,"given":"Jiaming","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Pantoja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2378-7198","authenticated-orcid":false,"given":"Guangjin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7018-6478","authenticated-orcid":false,"given":"Yongli","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7309-3736","authenticated-orcid":false,"given":"Bing","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,17]]},"reference":[{"key":"2512_CR1","doi-asserted-by":"publisher","first-page":"n2026","DOI":"10.1136\/bmj.n2026","volume":"375","author":"LF Newell","year":"2021","unstructured":"Newell LF, Cook RJ. Advances in acute myeloid leukemia. BMJ. 2021;375:n2026.","journal-title":"BMJ"},{"key":"2512_CR2","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/s41591-022-01819-x","volume":"28","author":"AGX Zeng","year":"2022","unstructured":"Zeng AGX, Bansal S, Jin L, Mitchell A, Chen WC, Abbas HA, et al. A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia. Nat Med. 2022;28:1212\u201323.","journal-title":"Nat Med"},{"key":"2512_CR3","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1172\/JCI129204","volume":"130","author":"L Vago","year":"2020","unstructured":"Vago L, Gojo I. Immune escape and immunotherapy of acute myeloid leukemia. J Clin Investig. 2020;130:1552\u201364.","journal-title":"J Clin Investig"},{"key":"2512_CR4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nrg.2016.59","volume":"17","author":"CD Allis","year":"2016","unstructured":"Allis CD, Jenuwein T. The molecular hallmarks of epigenetic control. Nat Rev Genet. 2016;17:487\u2013500.","journal-title":"Nat Rev Genet"},{"key":"2512_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3389\/fgene.2019.00133","volume":"10","author":"SL Goldman","year":"2019","unstructured":"Goldman SL, Hassan C, Khunte M, Soldatenko A, Jong Y, Afshinnekoo E, et al. Epigenetic modifications in acute myeloid leukemia: prognosis, treatment, and heterogeneity. Front Genet. 2019;10:133.","journal-title":"Front Genet"},{"key":"2512_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01197-3","volume":"19","author":"Y Lu","year":"2020","unstructured":"Lu Y, Chan YT, Tan HY, Li S, Wang N, Feng Y. Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy. Mol Cancer. 2020;19:79.","journal-title":"Mol Cancer"},{"key":"2512_CR7","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/s41375-021-01225-1","volume":"35","author":"L Yao","year":"2021","unstructured":"Yao L, Yin H, Hong M, Wang Y, Yu T, Teng Y, et al. RNA methylation in hematological malignancies and its interactions with other epigenetic modifications. Leukemia. 2021;35:1243\u201357.","journal-title":"Leukemia"},{"key":"2512_CR8","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1073\/pnas.71.10.3971","volume":"71","author":"R Desrosiers","year":"1974","unstructured":"Desrosiers R, Friderici K, Rottman F. Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc Natl Acad Sci USA. 1974;71:3971\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2512_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nchembio.1432","volume":"10","author":"J Liu","year":"2014","unstructured":"Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L, et al. A METTL3\u2013METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10:93\u20135.","journal-title":"Nat Chem Biol"},{"key":"2512_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","volume":"22","author":"H Weng","year":"2018","unstructured":"Weng H, Huang H, Wu H, Qin X, Zhao BS, Dong L, et al. METTL14 inhibits hematopoietic stem\/progenitor differentiation and promotes leukemogenesis via mRNA m(6)A modification. Cell Stem Cell. 2018;22:191\u2013205.e9.","journal-title":"Cell Stem Cell"},{"key":"2512_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06898-4","volume":"9","author":"Y Wu","year":"2018","unstructured":"Wu Y, Xie L, Wang M, Xiong Q, Guo Y, Liang Y, et al. Mettl3-mediated m(6)A RNA methylation regulates the fate of bone marrow mesenchymal stem cells and osteoporosis. Nat Commun. 2018;9:4772.","journal-title":"Nat Commun"},{"key":"2512_CR12","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.immuni.2020.05.003","volume":"52","author":"Y Gao","year":"2020","unstructured":"Gao Y, Vasic R, Song Y, Teng R, Liu C, Gbyli R, et al. m(6)A Modification prevents formation of endogenous double-stranded RNAs and deleterious innate immune responses during hematopoietic development. Immunity. 2020;52:1007\u201321.e8.","journal-title":"Immunity"},{"key":"2512_CR13","doi-asserted-by":"publisher","first-page":"e20200829","DOI":"10.1084\/jem.20200829","volume":"218","author":"C Mapperley","year":"2021","unstructured":"Mapperley C, van de Lagemaat LN, Lawson H, Tavosanis A, Paris J, Campos J, et al. The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function. J Exp Med. 2021;218:e20200829.","journal-title":"J Exp Med"},{"key":"2512_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.stem.2021.09.014","volume":"29","author":"R Yin","year":"2022","unstructured":"Yin R, Chang J, Li Y, Gao Z, Qiu Q, Wang Q, et al. Differential m(6)A RNA landscapes across hematopoiesis reveal a role for IGF2BP2 in preserving hematopoietic stem cell function. Cell Stem Cell. 2022;29:149\u201359.e7.","journal-title":"Cell Stem Cell"},{"key":"2512_CR15","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nature24678","volume":"552","author":"I Barbieri","year":"2017","unstructured":"Barbieri I, Tzelepis K, Pandolfini L, Shi J, Millan-Zambrano G, Robson SC, et al. Promoter-bound METTL3 maintains myeloid leukaemia by m(6)A-dependent translation control. Nature. 2017;552:126\u201331.","journal-title":"Nature"},{"key":"2512_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40164-023-00386-2","volume":"12","author":"WW Liu","year":"2023","unstructured":"Liu WW, Zhang ZY, Wang F, Wang H. Emerging roles of m6A RNA modification in cancer therapeutic resistance. Exp Hematol Oncol. 2023;12:21.","journal-title":"Exp Hematol Oncol"},{"key":"2512_CR17","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/nm.4416","volume":"23","author":"LP Vu","year":"2017","unstructured":"Vu LP, Pickering BF, Cheng Y, Zaccara S, Nguyen D, Minuesa G, et al. The N(6)-methyladenosine (m(6)A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat Med. 2017;23:1369\u201376.","journal-title":"Nat Med"},{"key":"2512_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.stem.2022.12.006","volume":"30","author":"L Han","year":"2023","unstructured":"Han L, Dong L, Leung K, Zhao ZC, Li YC, Gao L, et al. METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism. Cell Stem Cell. 2023;30:52.","journal-title":"Cell Stem Cell"},{"key":"2512_CR19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41586-022-05566-4","volume":"613","author":"J Li","year":"2023","unstructured":"Li J, Wang L, Hahn Q, Nowak RP, Viennet T, Orellana EA, et al. Structural basis of regulated m(7)G tRNA modification by METTL1-WDR4. Nature. 2023;613:391\u20137.","journal-title":"Nature"},{"key":"2512_CR20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41586-022-05565-5","volume":"613","author":"VM Ruiz-Arroyo","year":"2023","unstructured":"Ruiz-Arroyo VM, Raj R, Babu K, Onolbaatar O, Roberts PH, Nam Y. Structures and mechanisms of tRNA methylation by METTL1-WDR4. Nature. 2023;613:383\u201390.","journal-title":"Nature"},{"key":"2512_CR21","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1016\/j.molcel.2021.06.031","volume":"81","author":"EA Orellana","year":"2021","unstructured":"Orellana EA, Liu Q, Yankova E, Pirouz M, De Braekeleer E, Zhang WC, et al. METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation. Molecular Cell. 2021;81:3323.","journal-title":"Molecular Cell"},{"key":"2512_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40164-024-00477-8","volume":"13","author":"P Zhao","year":"2024","unstructured":"Zhao P, Xia L, Chen D, Xu W, Guo H, Xu Y, et al. METTL1 mediated tRNA m(7)G modification promotes leukaemogenesis of AML via tRNA regulated translational control. Exp Hematol Oncol. 2024;13:8.","journal-title":"Exp Hematol Oncol"},{"key":"2512_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05646-y","volume":"9","author":"ME Jakobsson","year":"2018","unstructured":"Jakobsson ME, Malecki JM, Halabelian L, Nilges BS, Pinto R, Kudithipudi S, et al. The dual methyltransferase METTL13 targets N terminus and Lys55 of eEF1A and modulates codon-specific translation rates. Nat Commun. 2018;9:3411.","journal-title":"Nat Commun"},{"key":"2512_CR24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.cell.2018.11.038","volume":"176","author":"S Liu","year":"2019","unstructured":"Liu S, Hausmann S, Carlson SM, Fuentes ME, Francis JW, Pillai R, et al. METTL13 methylation of eEF1A increases translational output to promote tumorigenesis. Cell. 2019;176:491.","journal-title":"Cell"},{"key":"2512_CR25","doi-asserted-by":"publisher","first-page":"166357","DOI":"10.1016\/j.bbadis.2022.166357","volume":"1868","author":"B Long","year":"2022","unstructured":"Long B, Shan Y, Sun Y, Wang T, Li X, Huang K, et al. Vitamin C promotes anti-leukemia of DZNep in acute myeloid leukemia. Biochim Biophys Acta Mol Basis Dis. 2022;1868:166357.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2512_CR26","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1182\/blood-2005-02-0734","volume":"106","author":"H Luo","year":"2005","unstructured":"Luo H, Li Q, O\u2019Neal J, Kreisel F, Le Beau MM, Tomasson MH. c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations. Blood. 2005;106:2452\u201361.","journal-title":"Blood"},{"key":"2512_CR27","doi-asserted-by":"publisher","first-page":"103756","DOI":"10.1016\/j.ebiom.2021.103756","volume":"75","author":"V Llombart","year":"2022","unstructured":"Llombart V, Mansour MR. Therapeutic targeting of \u201cundruggable\u201d MYC. EBioMedicine. 2022;75:103756.","journal-title":"EBioMedicine"},{"key":"2512_CR28","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1093\/molbev\/msab267","volume":"38","author":"JM Wong","year":"2021","unstructured":"Wong JM, Eirin-Lopez JM. Evolution of methyltransferase-like (METTL) proteins in metazoa: a complex gene family involved in epitranscriptomic regulation and other epigenetic processes. Mol Biol Evol. 2021;38:5309\u201327.","journal-title":"Mol Biol Evol"},{"key":"2512_CR29","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41422-019-0230-z","volume":"29","author":"L Malbec","year":"2019","unstructured":"Malbec L, Zhang T, Chen YS, Zhang Y, Sun BF, Shi BY, et al. Dynamic methylome of internal mRNA N(7)-methylguanosine and its regulatory role in translation. Cell Res. 2019;29:927\u201341.","journal-title":"Cell Res"},{"key":"2512_CR30","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.molcel.2019.03.036","volume":"74","author":"LS Zhang","year":"2019","unstructured":"Zhang LS, Liu C, Ma H, Dai Q, Sun HL, Luo G, et al. Transcriptome-wide mapping of internal N(7)-methylguanosine methylome in mammalian mRNA. Mol Cell. 2019;74:1304\u201316.e8.","journal-title":"Mol Cell"},{"key":"2512_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13045-022-01285-5","volume":"15","author":"Y Luo","year":"2022","unstructured":"Luo Y, Yao Y, Wu P, Zi X, Sun N, He J. The potential role of N(7)-methylguanosine (m7G) in cancer. J Hematol Oncol. 2022;15:63.","journal-title":"J Hematol Oncol"},{"key":"2512_CR32","doi-asserted-by":"publisher","first-page":"926296","DOI":"10.3389\/fonc.2022.926296","volume":"12","author":"B Zhang","year":"2022","unstructured":"Zhang B, Li D, Wang R. Transcriptome profiling of N7-methylguanosine modification of messenger RNA in drug-resistant acute myeloid leukemia. Front Oncol. 2022;12:926296.","journal-title":"Front Oncol"},{"key":"2512_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4149\/neo_2017_115","volume":"64","author":"SM Wang","year":"2017","unstructured":"Wang SM, Ye M, Zhou J, Ni SM, Wei QC. FEAT expression correlates with tumor size, PR status, HER2 expression, Ki67 index, and molecular subtype and predicts recurrence in breast cancer. Neoplasma. 2017;64:123\u201330.","journal-title":"Neoplasma"},{"key":"2512_CR34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41368-021-00130-8","volume":"13","author":"X Wang","year":"2021","unstructured":"Wang X, Li K, Wan Y, Chen F, Cheng M, Xiong G, et al. Methyltransferase like 13 mediates the translation of Snail in head and neck squamous cell carcinoma. Int J Oral Sci. 2021;13:26.","journal-title":"Int J Oral Sci"},{"key":"2512_CR35","doi-asserted-by":"publisher","first-page":"e3476","DOI":"10.1002\/jgm.3476","volume":"25","author":"H Ni","year":"2023","unstructured":"Ni H, Liang C, Zhou Z, Jiang B, Li Y, Shang H, et al. METTL13 promotes nasopharyngeal carcinoma progression through regulating the ZEB1\/TPT1 axis. J Gene Med. 2023;25:e3476.","journal-title":"J Gene Med"},{"key":"2512_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s12079-022-00687-x","volume":"17","author":"Q Wu","year":"2023","unstructured":"Wu Q, Hu Q, Hai Y, Li Y, Gao Y. METTL13 facilitates cell growth and metastasis in gastric cancer via an eEF1A\/HN1L positive feedback circuit. J Cell Commun Signal. 2023;17:121\u201335.","journal-title":"J Cell Commun Signal"},{"key":"2512_CR37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1182\/blood.2020009676","volume":"138","author":"M Feng","year":"2021","unstructured":"Feng M, Xie X, Han G, Zhang T, Li Y, Li Y, et al. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner. Blood. 2021;138:71\u201385.","journal-title":"Blood"},{"key":"2512_CR38","doi-asserted-by":"publisher","first-page":"5831","DOI":"10.7150\/thno.55574","volume":"11","author":"K Sun","year":"2021","unstructured":"Sun K, Du Y, Hou Y, Zhao M, Li J, Du Y, et al. Saikosaponin D exhibits anti-leukemic activity by targeting FTO\/m(6)A signaling. Theranostics. 2021;11:5831\u201346.","journal-title":"Theranostics"},{"key":"2512_CR39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13045-023-01477-7","volume":"16","author":"YN Qi","year":"2023","unstructured":"Qi YN, Liu Z, Hong LL, Li P, Ling ZQ. Methyltransferase-like proteins in cancer biology and potential therapeutic targeting. J Hematol Oncol. 2023;16:89.","journal-title":"J Hematol Oncol"},{"key":"2512_CR40","doi-asserted-by":"publisher","first-page":"11423","DOI":"10.1093\/nar\/gkae816","volume":"52","author":"PO Falnes","year":"2024","unstructured":"Falnes PO. Closing in on human methylation-the versatile family of seven-beta-strand (METTL) methyltransferases. Nucleic Acids Res. 2024;52:11423\u201341.","journal-title":"Nucleic Acids Res"},{"key":"2512_CR41","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41586-019-1016-7","volume":"567","author":"H Huang","year":"2019","unstructured":"Huang H, Weng H, Zhou K, Wu T, Zhao BS, Sun M, et al. Histone H3 trimethylation at lysine 36 guides m(6)A RNA modification co-transcriptionally. Nature. 2019;567:414\u20139.","journal-title":"Nature"},{"key":"2512_CR42","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/s41588-020-0677-3","volume":"52","author":"Y Li","year":"2020","unstructured":"Li Y, Xia L, Tan K, Ye X, Zuo Z, Li M, et al. N(6)-Methyladenosine co-transcriptionally directs the demethylation of histone H3K9me2. Nat Genet. 2020;52:870\u20137.","journal-title":"Nat Genet"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02512-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02512-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02512-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T15:03:16Z","timestamp":1747494196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02512-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,17]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2512"],"URL":"https:\/\/doi.org\/10.1038\/s41420-025-02512-x","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,17]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"AML samples were collected after obtaining informed consent in accordance with the Declaration of Helsinki. The study was approved by the ethics committees of the Institutional Review Boards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"240"}}